These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7027546)

  • 21. Inhibition of anti-skin allograft immunity induced by infusions with photoinactivated effector T lymphocytes--the congenic model.
    Perez MI; Berger CL; Yamane Y; John L; Laroche L; Edelson RL
    Transplantation; 1991 Jun; 51(6):1283-9. PubMed ID: 1828639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens.
    Halle-Pannenko O; Pritchard LL; Rappaport H
    Transplantation; 1983 Jul; 36(1):60-8. PubMed ID: 6223422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged adult skin allograft survival as a result of cotransplantation with neonatal tissue. The requirement for antigen sharing between graft and cotransplant.
    Markees TG; De Fazio SR; Gozzo JJ
    Transplantation; 1992 Dec; 54(6):955-8. PubMed ID: 1465789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease.
    Van Elven EH; Rolink AG; Veen FV; Gleichmann E
    J Exp Med; 1981 Jun; 153(6):1474-88. PubMed ID: 6454750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse skin allograft model for study of pregraft blood transfusion.
    Maki T; Okazaki H; Wood ML; Monaco AP
    Transplant Proc; 1982 Jun; 14(2):394-6. PubMed ID: 7051485
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhanced survival of skin grafts depleted of Langerhans' cells by treatment with dimethylbenzanthracene.
    Odling KA; Halliday GM; Muller HK
    Immunology; 1987 Nov; 62(3):379-85. PubMed ID: 3117676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of drug timing and histoincompatibility barrier in prolongation of cardiac graft survival in mice treated with donor-specific blood and cyclophosphamide.
    Lasek W; Jakóbisiak M; Płodzisewska M; Szczytnicki W; Górecki D
    Immunol Lett; 1988 Apr; 17(4):357-60. PubMed ID: 3286491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of unresponsiveness to skin allografts in adult mice disparate at defined regions of the H-2 complex. I. Effect of donor-specific bone marrow in ALS-treated mice.
    Wood ML; Monaco AP
    Transplantation; 1984 Jan; 37(1):35-9. PubMed ID: 6364486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants.
    Russell PS; Chase CM; Colvin RB; Plate JM
    J Exp Med; 1978 May; 147(5):1449-68. PubMed ID: 148488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. I. Genetics and specificity of anti-Ia immunotherapy in murine skin allograft recipients.
    Perry LL; Williams IR
    J Immunol; 1985 May; 134(5):2935-41. PubMed ID: 2580008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic aspects of the blood transfusion effect.
    Peugh WN; Wood KJ; Morris PJ
    Transplantation; 1988 Sep; 46(3):438-43. PubMed ID: 3047933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newborn blood used as a source of donor cells in a murine model of transplantation across non-MHC antigens.
    de la Selle V; Bruley-Rosset M
    Ann N Y Acad Sci; 1995 Dec; 770():351-60. PubMed ID: 8597373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
    Ishikawa H; Saito K; Kubota E
    J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of tolerance to non-H-2 alloantigens is not restricted by the MHC molecules expressed on the donor cells in cyclophosphamide-induced tolerance.
    Tomita Y; Nomoto K
    Immunobiology; 1990 Nov; 181(4-5):430-7. PubMed ID: 2099910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide.
    Tomita Y; Yoshikawa M; Zhang QW; Shimizu I; Okano S; Iwai T; Yasui H; Nomoto K
    J Immunol; 2000 Jul; 165(1):34-41. PubMed ID: 10861032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promotion of corneal allograft survival by the induction of oxidative macrophages.
    Yamada J; Maruyama K; Sano Y; Kinoshita S; Murata Y; Hamuro J
    Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):448-54. PubMed ID: 14744884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.